However, in the 4–99 epg infection group, there was a significant increase in CCL11 (p = 0.002) 3 months post-treatment, whereas, CCL5 and CXCL10 were significantly decreased (p = 0.009 and p = 0.002, respectively). The gene discussed is CXCL10; the disease is infection.